<code id='61C1B02070'></code><style id='61C1B02070'></style>
    • <acronym id='61C1B02070'></acronym>
      <center id='61C1B02070'><center id='61C1B02070'><tfoot id='61C1B02070'></tfoot></center><abbr id='61C1B02070'><dir id='61C1B02070'><tfoot id='61C1B02070'></tfoot><noframes id='61C1B02070'>

    • <optgroup id='61C1B02070'><strike id='61C1B02070'><sup id='61C1B02070'></sup></strike><code id='61C1B02070'></code></optgroup>
        1. <b id='61C1B02070'><label id='61C1B02070'><select id='61C1B02070'><dt id='61C1B02070'><span id='61C1B02070'></span></dt></select></label></b><u id='61C1B02070'></u>
          <i id='61C1B02070'><strike id='61C1B02070'><tt id='61C1B02070'><pre id='61C1B02070'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:57896
          Medical personnel wearing gloves adjust IV bags displayed on a conveyor belt. -- health policy coverage from STAT
          Civica Rx is considering a move into chemotherapies amid drug shortages. Adobe

          WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.

          Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.

          advertisement

          Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more
          Apellis safety probe of eye disease drug centers on injection needle
          Apellis safety probe of eye disease drug centers on injection needle

          AlexHogan/STATApellisPharmaceuticalssaidTuesdaythatithadidentified“internalstructuralvariations”inat

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          J&J to buy cancer drug developer Ambrx Biopharma

          AP/RichardDrewJohnson&JohnsonsaidMondaythatitwouldpurchaseAmbrxBiopharmafornearly$2billion,picki